Msd

2 products tracked · names used in filings: Msd

Upcoming milestones

No upcoming milestones listed.

Recent milestones

Wed 15 Jul 2026🇺🇸 FDA approval

FDA approves Lipfendra (enlicitide decanoate), a new medicine

Msd; NDA220848; New molecular entity, Priority review; tablet · source

Mon 20 Apr 2026🇺🇸 FDA approval

FDA approves Idvynso (doravirine, islatravir), a new medicine

Msd; NDA216964; New molecular entity; tablet · source

Products

ProductStatusApproved
🇺🇸Lipfendra
enlicitide decanoate		Approved2026-07-15
🇺🇸Idvynso
doravirine, islatravir		Approved2026-04-20

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.